ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism

scientific article

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1032143777
P356DOI10.1186/1471-2407-8-105
P932PMC publication ID2377272
P698PubMed publication ID18416817
P5875ResearchGate publication ID5435471

P50authorMarjanka K SchmidtQ37372106
Tom Van WezelQ42794317
Anne-Marie Cleton-JansenQ45924326
Laura J. van't VeerQ20581223
P2093author name stringAnne-Marie Cleton-Jansen
Ronald van Eijk
Johannes L Peterse
Cees J Cornelisse
Marcel Lombaerts
Katja Philippo
Rhyenne M E Zimmerman
Vincent T B H M Smit
P2860cites workRapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.Q31843692
NAD(P)H: quinone oxidoreductase 1 expression in kidney podocytesQ33346575
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.Q34144906
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexQ34476919
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.Q34497064
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1Q34654289
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantQ35443960
Search for unknown tumor‐antagonizing genesQ35563102
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.Q35789595
Repeat instability: mechanisms of dynamic mutationsQ36277189
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).Q36419978
A genome wide linkage search for breast cancer susceptibility genesQ37272982
Chemoprotection against cancer by phase 2 enzyme inductionQ40967020
Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter.Q42457506
Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer developmentQ43865718
Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systemsQ44279157
Ever since KnudsonQ53395377
20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcomeQ53610966
Breast Cancer Survival and Tumor Characteristics in Premenopausal Women Carrying theCHEK2*1100delCGermline MutationQ61970254
CTCF Gene Mutations in Invasive Ductal Breast CancerQ61970378
Effect of germ-line genetic variation on breast cancer survival in a population-based studyQ64387842
Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regionsQ73548870
Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancerQ80403559
Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoproteinQ22009543
A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingersQ24338438
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesQ24534395
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancersQ24597264
Mutation and cancer: statistical study of retinoblastomaQ24618185
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?Q24802136
Expression analysis of candidate breast tumour suppressor genes on chromosome 16qQ25257454
Systematic variation in gene expression patterns in human cancer cell linesQ28145747
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificityQ28215031
Germline ATBF1 mutations and prostate cancer riskQ28236517
Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancerQ28238392
NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogeneticsQ28252988
Infrequent mutation of ATBF1 in human breast cancerQ28260136
ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancerQ28304361
Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regionsQ30476046
Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1.Q31814757
P4510describes a project that useslimmaQ112236343
P407language of work or nameEnglishQ1860
P304page(s)105
P577publication date2008-04-16
P1433published inBMC CancerQ326300
P1476titleATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism
P478volume8

Reverse relations

cites work (P2860)
Q34236787ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells
Q34516351Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling
Q34799877Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells
Q35832016Genetic characterization of breast cancer and implications for clinical management
Q33369969Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer
Q57306207NQO1 expression correlates inversely with NFκB activation in human breast cancer
Q36011507Novel Nucleotide Variations, Haplotypes Structure and Associations with Growth Related Traits of Goat AT Motif-Binding Factor (ATBF1) Gene
Q24309768Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP
Q92116009Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q
Q60529794Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification
Q42742346TGF- β Signaling Cooperates with AT Motif-Binding Factor-1 for Repression of the α -Fetoprotein Promoter

Search more.